Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    19822627 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus
Conditions: H1N1 Influenza Virus;   Chronic Pulmonary Disease;   Chronic Heart Disease;   Diabetes Mellitus
Interventions: Biological: Focetria®;   Biological: Fluad®;   Biological: Begrivac®
2 Withdrawn A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects
Conditions: Influenza;   Flu
Intervention: Drug: Anti-influenza IVIG

Indicates status has not been verified in more than two years